Jim Momtazee

Directeur/Membre du Conseil chez ROIVANT SCIENCES LTD.

Profil

Jim Momtazee is the Managing Partner of Patient Square Capital.
Mr. Momtazee has 28 years of investment and acquisition experience, the vast majority of which was focused on the health care sector.
Prior to Patient Square, he spent over 21 years at KKR, initially joining in 1996.
He helped establish the firm’s health care industry group in 2001 and subsequently was Head of the Americas Health Care Team for over 10 years.
In that role, he managed a team of over 20 dedicated health care professionals overseeing five different health care-related investment strategies including private and growth equity.
He was a member of the Americas Private Equity Investment Committee beginning in 2013 and was Chairman of both the Health Care Strategic Growth and Health Care Royalty & Income Investment Committees.
Mr. Momtazee currently serves on the board of directors of Apollo Therapeutics, BridgeBio Pharma, Elevage Medical Technologies, Enavate Sciences, Kriya Therapeutics, the Medical Device Manufacturers Association, Roivant Sciences, and Syneos Health.
He previously served on the board of director of Ajax Health, Alliance Imaging, Arbor Pharmaceuticals, PharMerica, Covenant Surgical Partners, EchoNous, Entellus Medical, Envision Healthcare, Global Medical Response, HCA, Heartland Dental, Jazz Pharmaceuticals, Lake Region Medical, PRA Health Sciences, and Spirox.
Earlier in his career, Mr. Momtazee was one of three executives who moved to London to launch KKR’s European investing operations and also spent several months helping launch Accel-KKR, a software and technology-enabled services investment firm.
Prior to KKR, Mr. Momtazee worked at Donaldson, Lufkin & Jenrette and was involved in a broad range of merchant banking, M&A, debt, equity, and restructuring transactions.
Mr. Momtazee received a B.A.
with distinction, Phi Beta Kappa, from Stanford University and an M.B.A., Arjay Miller Scholar, from Stanford’s Graduate School of Business.

Postes actifs de Jim Momtazee

Sociétés	Poste	Début
ROIVANT SCIENCES LTD.	Directeur/Membre du Conseil	01/10/2021
BridgeBio Pharma LLC	Directeur/Membre du Conseil	01/03/2016
Patient Square Capital	Fondateur	01/07/2020
Alladapt Immunotherapeutics, Inc.	Directeur/Membre du Conseil	01/06/2022
Enavate Sciences	Président	01/05/2022
Kriya Therapeutics, Inc.	Directeur/Membre du Conseil	01/06/2021
Apollo Therapeutics Group Ltd.	Directeur/Membre du Conseil	-
Apollo Therapeutics LLP	Directeur/Membre du Conseil	01/06/2021

Anciens postes connus de Jim Momtazee

Sociétés	Poste	Fin
Global Medical Response, Inc.	Directeur/Membre du Conseil	31/07/2019
░░░░░░░░░ ░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Formation de Jim Momtazee

Stanford University	Undergraduate Degree
Stanford Graduate School of Business	Masters Business Admin